# An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

> **NCT02557308** · — · TERMINATED · sponsor: **Celltrion** · enrollment: 329 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02557308
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05-26
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 329 (ACTUAL)
- **Why stopped:** Terminated
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557308, "An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02557308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*